Riskpilot← Back to searchSign inGet full accessVRB Medical AB
ABActiveOrg 5569295552Hembyggarevägen 10General medical practice activities · NACE 8621Est. 20131-4 employees
Revenue 2025
SEK 3,8M
-6% vs 2024
EBITDA margin
41.3%
-22% vs 2024
Equity ratio
30.1%
Financial strength
Net profit 2025
SEK 448K
-45% vs 2024
| Revenue | SEK 3,8M | -6% |
| EBITDA | SEK 1,6M | -22% |
| Net profit | SEK 448K | -45% |
| Total assets | SEK 3M | -2% |
| Equity | SEK 897K | -6% |
| Employees | — | — |
Legal name
VRB Medical AB
Org number
5569295552
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 april 2013
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultverksamhet inom läkaryrket samt sjukvård och hälsovård och därmed förenlig verksamhet.
Address
Hembyggarevägen 10
Email
vrbmedical@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 810 | 3 796 | 4 092 | 4 030 | 3 803 |
| Staff expenses | — | — | — | −1 844 | −1 690 |
| EBITDA | 1 471 | 1 675 | 1 793 | 2 016 | 1 571 |
| Depreciation & amort. | −609 | −603 | −616 | −656 | −452 |
| EBIT | 862 | 1 072 | 1 177 | 1 360 | 1 119 |
| Net financials | −541 | −513 | −474 | −504 | −517 |
| Profit before tax | 227 | 506 | 469 | 1 044 | 581 |
| Tax | −58 | −113 | −107 | −223 | −133 |
| Net profit | 169 | 393 | 362 | 821 | 448 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 940 | 2 496 | 2 830 | 3 039 | 2 982 |
| Equity | 763 | 696 | 618 | 949 | 897 |
| Long-term debt | 778 | 485 | 590 | 934 | 1 069 |
| Short-term debt | 896 | 759 | 833 | 554 | 393 |
| Total debt | 1 674 | 1 244 | 1 423 | 1 488 | 1 463 |
EBITDA margin
41.3%
This company
15.8%
Market median
+161% vs market
20212025
Equity ratio
30.1%
This company
38.2%
Market median
+21% vs market
20212025
Return on equity
49.9%
This company
18.4%
Market median
+171% vs market
20212025
Net profit margin
11.8%
This company
8.1%
Market median
+46% vs market
20212025
Asset turnover
1.28×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
2.33×
This company
0.62×
Market median
-276% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LC | Audit | 2025 |
| Former (1) | ||
CR Chief Auditor | Chief Auditor | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VRB Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars-Inge Christer Persson | Audit | 0 companies |
| Clas Rydén | Chief Auditor | 0 companies |
| Violeta Aurelia Sbircea | Deputy Board Member | 0 companies |
| Bahram Haghighi | Board of Directors | 0 companies |